✦ LIBER ✦

Organ Preservation for Patients With Advanced Laryngeal Cancer Who Responded to Induction Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (TPF) Followed by Cisplatin Concomitant With Radiation Therapy: A Phase 2 Trial

✍ Scribed by Popovtzer, A.; Shvero, J.; Limon, D.; Burnstien, H.; Groshar, D.; Stemmer, S.

Book ID: 127220263
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 74 KB
Volume: 90
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.05.1619

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel, cisplatin, and fluorouracil i

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

✍ David J. Adelstein; James Moon; Ehab Hanna; P. G. Shankar Giri; Glenn M. Mills; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## Background In an effort to optimize nonoperative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology Group conducted a phase II trial combining 3‐drug taxane‐containing induction chemotherapy with accelerated fractionation/conc

Phase I trial of split-dose induction do

Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

✍ Katrin Oertel, Karin Spiegel, Harald Schmalenberg, Andreas Dietz, Georg Maschmey 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 218 KB

Induction chemotherapy with paclitaxel a

Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)

✍ Andreas Dietz; Volker Rudat; Jens Dreyhaupt; Maria Pritsch; Florian Hoppe; Rudol 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

A phase 2 trial of induction nab-paclita

A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck

✍ Douglas Adkins; Jessica Ley; Kathryn Trinkaus; Wade Thorstad; James Lewis Jr; Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

Cetuximab/Radiation Therapy (CET + RT) V

Cetuximab/Radiation Therapy (CET + RT) Versus Concomitant Chemoradiation Therapy (cCHT + RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head-and-Neck Squamous Cell Carcinoma (LASCCHN) – Preliminary Results on Toxicity of a Randomized, 2x2 Factorial, Phase II-III Study (NCT01086826)

✍ Ghi, M.; Paccagnella, A.; Orecchia, R.; Parisi, S.; Bertoni, F.; Minguzzi, N.; B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views